"Drug Monitoring" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The process of observing, recording, or detecting the effects of a chemical substance administered to an individual therapeutically or diagnostically.
Descriptor ID |
D016903
|
MeSH Number(s) |
E01.370.520.200
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Drug Monitoring".
Below are MeSH descriptors whose meaning is more specific than "Drug Monitoring".
This graph shows the total number of publications written about "Drug Monitoring" by people in this website by year, and whether "Drug Monitoring" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2002 | 0 | 1 | 1 |
2004 | 0 | 1 | 1 |
2006 | 0 | 3 | 3 |
2008 | 2 | 1 | 3 |
2009 | 1 | 1 | 2 |
2011 | 0 | 3 | 3 |
2012 | 1 | 1 | 2 |
2013 | 1 | 0 | 1 |
2015 | 1 | 0 | 1 |
2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug Monitoring" by people in Profiles.
-
McEvoy JP, Kremens DE. Early Recognition and Treatment of Tardive Dyskinesia in Patients With Mood Disorders and Schizophrenia. J Clin Psychiatry. 2020 Jan 28; 81(1).
-
Cuker A, Husseinzadeh H. Laboratory measurement of the anticoagulant activity of edoxaban: a systematic review. J Thromb Thrombolysis. 2015 Apr; 39(3):288-94.
-
Bernardo VA, Cross SJ, Crews KR, Flynn PM, Hoffman JM, Knapp KM, Pauley JL, Molinelli AR, Greene WL. Posaconazole therapeutic drug monitoring in pediatric patients and young adults with cancer. Ann Pharmacother. 2013 Jul-Aug; 47(7-8):976-83.
-
Gaur AH, Flynn PM, Bitar W, Liang H. Optimizing frequency of CD4 assays in the era of highly active antiretroviral therapy. AIDS Res Hum Retroviruses. 2013 Mar; 29(3):418-22.
-
Stefanacci RG, Haimowitz D. Taking the pain out of pain management. Geriatr Nurs. 2012 Sep-Oct; 33(5):391-7.
-
Nightingale G. Ofatumumab: a novel anti-CD20 monoclonal antibody for treatment of refractory chronic lymphocytic leukemia. Ann Pharmacother. 2011 Oct; 45(10):1248-55.
-
Swaby RF, Cristofanilli M. Circulating tumor cells in breast cancer: a tool whose time has come of age. BMC Med. 2011; 9:43.
-
Gulati G, Hevelow M, George M, Behling E, Siegel J. International normalized ratio versus plasma levels of coagulation factors in patients on vitamin K antagonist therapy. Arch Pathol Lab Med. 2011 Apr; 135(4):490-4.
-
Lestner JM, Roberts SA, Moore CB, Howard SJ, Denning DW, Hope WW. Toxicodynamics of itraconazole: implications for therapeutic drug monitoring. Clin Infect Dis. 2009 Sep 15; 49(6):928-30.
-
Anton BB, Schafer JJ, Micenko A, Wolf DM, DiNucci S, Donovan P, Jordan B. Clinical decision support. How CDS tools impact patient care outcomes. J Healthc Inf Manag. 2009; 23(1):39-45.